Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study.

Dae Ho LeeMing-Sound TsaoKarl-Otto KambartelHiroshi IsobeMing-Shyan HuangCarlos H BarriosAdnan KhattakFilippo de MarinisSmita KothariAshwini ArunachalamXiting CaoThomas BurkeAmparo ValladaresJavier de Castro

Published in: PloS one (2018)

We observed substantial variation among countries in testing percentages, treatment patterns, and survival outcomes. Efforts to optimize molecular testing rates should be implemented in the context of each country's health care scenario.

Keyphrases

advanced non small cell lung cancer
healthcare
epidermal growth factor receptor
single molecule
combination therapy
smoking cessation